Inhaled iloprost
Sponsors
University of Chicago, Carmel Medical Center, Duke University, Heidelberg University, Yonsei University
Conditions
ARDS, HumanCOVID-19Chronic Left Ventricular FailureChronic Obstructive Pulmonary DiseaseHypoxemic Respiratory FailureLung CancerPulmonary HypertensionVideo-assisted Thoracoscopic Surgery
Phase 2
Phase 4
Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
TerminatedNCT00409526
Start: 2006-12-31End: 2007-12-31Updated: 2014-06-02
Inhaled Iloprost for Disproportionate Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)
NCT01116063
Start: 2010-05-31End: 2013-06-30Target: 15Updated: 2010-05-04
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
TerminatedNCT02170519
Start: 2006-09-30End: 2009-01-31Updated: 2024-10-15
Unknown Phase
Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
CompletedNCT02490657
Start: 2015-07-31End: 2016-05-31Updated: 2016-06-21
The Effect of Iloprost on Oxygenation During One-lung Ventilation for Lung Surgery
CompletedNCT03936140
Start: 2018-01-04End: 2018-10-24Updated: 2019-05-03